- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
8
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
8 companies
TTY Biopharm
Market Cap: NT$18.9b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$76.10
7D
-0.5%
1Y
-0.4%
Cenra
Market Cap: NT$5.1b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$34.80
7D
-0.4%
1Y
1.2%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$40.30
7D
-0.2%
1Y
-6.1%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.75
7D
4.4%
1Y
36.9%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.50
7D
-0.6%
1Y
7.9%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$29.85
7D
0%
1Y
-5.6%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$782.1m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$8.69
7D
-2.7%
1Y
-23.1%
Bioray Biotech
Market Cap: NT$505.9m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$17.10
7D
0%
1Y
-37.9%